Exercise in Hypoxia and Nitrate Supplementation in Athletes: is the Whole Greater Than the Sum of Its Parts?
1 other identifier
interventional
30
1 country
1
Brief Summary
Determine the combined effect of training in hypoxia and nitrate supplementation on the performance and health of athletes at sea-level and altitude conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 22, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 22, 2020
CompletedFirst Submitted
Initial submission to the registry
July 24, 2024
CompletedFirst Posted
Study publicly available on registry
December 11, 2024
CompletedDecember 11, 2024
December 1, 2024
1.5 years
July 24, 2024
December 4, 2024
Conditions
Outcome Measures
Primary Outcomes (11)
Performance adaptations
Time-to-task failure (time sustained)
Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)
Performance adaptations
Time trials (time performed)
Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)
Performance adaptations
VO2 kinetics (time constant and amplitude of fast and slow oxygen components)
Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)
Cardiovascular and neuromuscular adaptations
Maximal oxygen uptake (VO2max: absolute and relative value)
Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)
Cardiovascular and neuromuscular adaptations
Lactate threshold (absolute and percentage of VO2max)
Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)
Cardiovascular and neuromuscular adaptations
Muscular oxygen saturation (SmO2)
Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)
Skeletal muscle adaptations
Oxidative enzyme activity (cytochrome oxidase subunit IV), citrate synthase, transcription factors (HIF-1alpha and PGC-1alpha) and GLUT4 - assessed through standard enzymatic fluorometric assay and western bllotting
Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)
Skeletal muscle adaptations
Mitochondrial and capillary density, capillary-to-fibre ratio and fibre cross-section area - cryosections cut with a cryostat and further samples analysed by fluorescence microscopy
Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)
Haematological adaptations
Blood pressure (Hmmg), mean arterial pressure (calculated as 1/3 \* systolic pressure + 2/3 \* diastolic pressure)
Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)
Haematological adaptations
Plasma \[NO2-\] and \[NO3-\], erythropoietin (EPO), haemoglobin (Hb) and haematocrit (Hct) - all assays on plasma sample analysed by spectrophometry
Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)
Oxidative stress and antioxidant markers adaptations
Nitrotyrosine, malondialdehyde, ferric-reducing antioxidant power and superoxide dismutase concentrations - all assays on plasma sample analysed by spectrophometry
Moment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)
Secondary Outcomes (5)
Sleep and cardiac autonomic activity adaptations
Moment #1 (2 weeks pre-intervention - baseline) and moment #2 (4 weeks intervention)
Sleep and cardiac autonomic activity adaptations
Moment #1 (2 weeks pre-intervention - baseline) and moment #2 (4 weeks intervention)
Sleep and cardiac autonomic activity adaptations
Moment #1 (2 weeks pre-intervention - baseline) and moment #2 (4 weeks intervention)
Sleep and cardiac autonomic activity adaptations
Moment #1 (2 weeks pre-intervention - baseline) and moment #2 (4 weeks intervention)
Sleep and cardiac autonomic activity adaptations
Moment #1 (2 weeks pre-intervention - baseline) and moment #2 (4 weeks intervention)
Study Arms (3)
HNO: High intensity interval training (HIIT) + nitrate supllementation (NO3-).
EXPERIMENTALPerformed 12 high-intensity interval-training (HIIT) sessions during a 4-week period (3 sessions/ week) under normobaric hypoxia conditions (FiO2=\~13%, \~3000 m) with NO3- supplement.
HPL: High intensity interval training (HIIT) + placebo supllementation.
ACTIVE COMPARATORPerformed 12 high-intensity interval-training (HIIT) sessions during a 4-week period (3 sessions/ week) under normobaric hypoxia conditions (FiO2=\~13%, \~3000 m) with placebo supplement.
CON: High intensity interval training (HIIT) + placebo supllementation.
PLACEBO COMPARATORPerformed 12 high-intensity interval-training (HIIT) sessions during a 4-week period (3 sessions/ week) under normoxic conditions (FiO2=\~20.9%) with placebo supplement.
Interventions
The combined effect of nitrate supplementation and hypoxia training on both performance and health at sea-level and altitude conditions.
The combined effect of placebo supplementation and hypoxia training on both performance and health at sea-level and altitude conditions.
The combined effect of placebo supplementation and normoxia training on both performance and health at sea-level and altitude conditions.
Eligibility Criteria
You may qualify if:
- trained male subjects, regularly involved in competitive running, cycling and/ or triathlon events (4-5 times per week) in the past five years
You may not qualify if:
- smoking or other chronic issues
- using medication or dietary supplements in the last 3 months, or during the duration of the study
- being exposed to altitude (≥2000 m) in the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Trás-os-Montes e Alto-Douro
Vila Real, Portugal
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ana Sousa, PhD
University of Maia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
July 24, 2024
First Posted
December 11, 2024
Study Start
February 1, 2019
Primary Completion
July 22, 2020
Study Completion
July 22, 2020
Last Updated
December 11, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
Study overview, participation criteria, study plan, contacts